Sr./Principal Medical Science Liaison - Remote

Overview

The Sr./Principal Medical Science Liaison (MSL) is a field-based scientific expert responsible for communicating with a variety of internal and external stakeholders, providing medical and scientific information on the appropriate utilization of therapy(s), and advancing therapeutic disease state knowledge.

In Short

• Field-based role focused on medical affairs and scientific communication.
• Develop and execute comprehensive territory medical plans.
• Engage with healthcare professionals and key opinion leaders.
• Deliver scientific presentations and attend conferences.
• Collaborate with commercial teams on scientific intelligence.
• Conduct post-marketing research and support clinical studies.
• Manage relationships with advocacy groups and professional societies.
• Provide training and mentorship to new hires and colleagues.
• Travel required (50-60% of the time).
• Support team development and management efforts.

Requirements

• Advanced healthcare degree (PharmD, Ph.D., MD) preferred.
• 3+ years of medical affairs or field medical experience.
• Experience in rare diseases or skeletal dysplasia is a plus.
• Excellent communication and presentation skills.
• Ability to engage in scientific dialogue with KOLs.
• Strong relationship-building skills with industry leaders.
• Understanding of clinical research and pharmaceutical development.
• Ability to work independently in a dynamic environment.
• Willingness to travel extensively.
• Management responsibilities for a small team may apply.

Benefits

• Patient-focused culture and values.
• Comprehensive career development programming.
• Market-competitive compensation and benefits package.
• Flexible PTO and rapid career advancement opportunities.
• Access to learning and development resources.
• Commitment to Diversity, Equity & Inclusion.
• Collaborative and fast-paced work environment.
• Potential to work on multiple therapeutic programs.
• Partnerships with leading institutions.
• Employee engagement with patients and advocacy groups.